Corbion reported Q4 2014 sales of € 200.6 million, an 8.7% increase compared to Q4 2013, driven by organic sales growth (2.9%) and currencies (5.8%). The Biobased Ingredients business unit grew sales organically by 2.0%; this comprised flat growth at Food, and 8.2% growth in Biochemicals. EBITDA before one-off costs in Q4 2014 increased significantly by 35.9% to € 30.3 million. Organic EBITDA growth in Q4 2014 amounted to 26.0%.
Recommended Reading
-
Corbion today announces that the Chair of its Supervisory Board, Ilona Haaijer, has informed the Supervisory Board that for personal reasons she has decided to step down from her position as Chair and...
Read More -
The annual Corbion General Shareholders Meeting held on 13 May 2026 approved the appointments of Per Falholt and Bob Elfring as members of the Supervisory Board. Per Falholt brings over 40 years of...
Read More